Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
US10138253B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2016 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Aug 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4985
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.